Skip to main content
NCBI home page
Technology in Cancer Research & Treatment logoLink to Technology in Cancer Research & Treatment
. 2018 Aug 15;17:1533033818789635. doi: 10.1177/1533033818789635

Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line

Zhimin Fu 1,2, Xiaocheng Cao 3, Yi Yang 4, Zhenwei Song 3, Jiansong Zhang 3, Zheng Wang 2,✉
PMCID: PMC6096686  PMID: 30111255

Abstract

Manganese superoxide dismutase promotes migration and invasion in lung cancer cells via upregulation of the transcription factor forkhead box M1. Here, we assessed whether upregulation of forkhead box M1 by manganese superoxide dismutase overexpression mediates the acquisition of cancer stem-like cell characteristics in non-small cell lung cancer H460 cells. The second-generation spheroids from H460 cells were used as lung cancer stem-like cells. The levels of manganese superoxide dismutase, forkhead box M1, stemness markers (CD133, CD44, and ALDH1), and transcription factors (Bmi1, Nanog, and Sox2) were analyzed by Western blot. Sphere formation in vitro and carcinogenicity of lung cancer stem-like cells were evaluated by spheroid formation assay and limited dilution xenograft assays. Knockdown or overexpression of manganese superoxide dismutase or/and forkhead box M1 by transduction with short hairpin RNA(shRNA) or complementary DNA were performed for mechanistic studies. We showed that manganese superoxide dismutase and forkhead box M1 amounts as well as the expression levels of stemness markers and transcription factors sphere formation in vitro, and carcinogenicity of lung cancer stem-like cells were higher than in monolayer cells. Lung cancer stem-like cells transduced with manganese superoxide dismutase shRNA or FoxM1 shRNA exhibited decreased sphere formation and lower amounts of stemness markers and transcription factors. Overexpression of manganese superoxide dismutase or FoxM1 in H460 cells resulted in elevated sphere formation rates and protein levels of stemness markers and transcription factors. Meanwhile, manganese superoxide dismutase knockdown or overexpression accordingly altered forkhead box M1 levels. However, forkhead box M1 knockdown or overexpression had no effect on manganese superoxide dismutase levels but inhibited or promoted lung cancer stem-like cell functions. Interestingly, forkhead box M1 overexpression alleviated the inhibitory effects of manganese superoxide dismutase knockdown in lung cancer stem-like cells. In a panel of non-small cell lung cancer cells, including H441, H1299, and H358 cells, compared to the respective monolayer counterparts, the expression levels of manganese superoxide dismutase and forkhead box M1 were elevated in the corresponding spheroids. These findings revealed the role of forkhead box M1 upregulation by manganese superoxide dismutase overexpression in maintaining lung cancer stem-like cell properties. Therefore, inhibition of forkhead box M1 upregulation by manganese superoxide dismutase overexpression may represent an effective therapeutic strategy for non-small cell lung cancer.

Keywords: cancer stem-like cell, FoxM1, lung cancer, MnSOD, self-renewal

Introduction

Advances in the understanding of tumor cell biology have focused on cancer stem cells (CSCs) or cancer stem-like cells (CSLCs), an etiogenic cell subset in tumorigenesis.1 Cancer stem-like cells are considered to be responsible for oncogenicity in a variety of carcinomas.2–4 Our research team previously demonstrated CSLCs contribute to self-renewal, migration, and invasion of the non-small cell lung carcinoma (NSCLC) A549 cell line.5 Therefore, elucidating the molecular mechanisms underlying the critical roles of CSLCs in NSCLC oncogenicity is extremely important. Because mitochondria either directly control cell metabolism or constitute a critical node in cell signaling, altered mitochondrial activity and uncontrolled cell division might lead to tumorigenesis and malignancy.6

Manganese superoxide dismutase (MnSOD), a mitochondrial protein, catalyzes the transformation of the superoxide anion radical into H2O2 and oxygen to modulate cellular signaling pathways.6,7 The function of MnSOD in carcinogenesis and malignancy remains a subject of debate; however, a study by Chen et al demonstrated that MnSOD enhances migration and invasion by upregulating the forkhead box M1 (FoxM1) transcription factor, with elevated MnSOD amounts considered an independent predictive factor of survival and relapse in lung cancer.8 Nevertheless, whether and how MnSOD affects stem-like spheroid formation by lung cancer cells still requires adequate clarification.

Forkhead box M1 is highly expressed in proliferating cells and participates in cell cycle progression.9 Because FoxM1 is overexpressed in various human cancers, including lung cancer,10,11 it has been hypothesized to be implicated in tumorigenesis. It was shown that Mx-Cre FoxM1−/− mutant mice have significantly reduced lung adenomas, thanks to tumor cell inhibition. Conversely, FoxM1 overexpressing animals show more and larger tumors after treatment with 3-methylcholanthrene/butylated hydroxytoluene, as well as increased cell division in transplant tumors, in comparison to wild-type mice. In contrast, lung tumor number and size for FoxM1 knockdown mouse respiratory epithelial cells were shown to be significantly decreased.12 These findings clearly reveal an association of FoxM1 with lung oncogenicity. In addition, FoxM1 contributes to the acquisition of cancer stem properties and the epithelial–mesenchymal transition phenotype in several cancers.13,14 The abovementioned evidences prompted the hypothesis that MnSOD might upregulate FoxM1, thereby promoting the acquisition of cancer stem properties in NSCLC.

The present study demonstrated that elevated MnSOD levels resulted in increased FoxM1 amounts, conferring stemness to the NSCLC H460 cell line. We also demonstrated that MnSOD overexpression triggers FoxM1 upregulation to induce and maintain self-renewal features, thus promoting tumor development and progression in NSCLC.

Materials and Methods

Reagents

Invitrogen Life Technologies (Shanghai, China) manufactured Dulbecco modified Eagle medium (DMEM) and DMEM/F12 medium; Trypsin-EDTA, fetal bovine serum (FBS), and Penicillin-streptomycin. All cell culture dishes were provided by Corning Life Sciences (New York, USA).

Monoclonal antibodies raised in mice against human anti-β-actin were manufactured by Sigma-Aldrich (Catalog No. A2066, St Louis, Missouri, USA). Rabbit polyclonal antibodies targeting CD44, ALDH1A1, CD133, Oct4, Nanog, and MnSOD were obtained from Abcam Company (Catalog No. ab24504, ab9883, ab19898, ab18976, ab109250, and ab13533; Cambridge, Massachusetts). Monoclonal antibodies raised against Bmi1 in mice were provided by Abcam Company (Catalog No. ab126783). Monoclonal antibodies raised against FoxM1 in rabbits (C-20) were manufactured by Santa Cruz Biotechnology, Inc. (Catalog No. sc-502; Beverly, Massachusetts).

The pHBad-MCMV-GFP, pHBad-U6-GFP, pHBad-MCMV-GFP-MnSOD, pHBad-MCMV-GFP-FoxM1, pHBad-U6-GFP-sh MnSOD, and pHBad-U6-GFP-sh FoxM1 plasmid packaging adenoviral particles were obtained from Hanbio Biotechnology Co Ltd (2.0 mL, 1 × 1011 PFU/ mL; Shanghai, China).

Cell Culture and Sphere Formation Assay

Human NSCLC H460, H441, H1299, and H358 cells (Chinese Academy of Sciences, Shanghai, China) were maintained in DMEM containing 10% FBS with penicillin and streptomycin in a humid environment containing 5% CO2 at 37°C.

For sphere formation, serum-free culture medium containing 20 ng/mL of human recombinant basic fibroblast growth factor and human recombinant epidermal growth factor, 5 μg/mL insulin (Sigma-Aldrich), 0.4% bovine serum albumin (Invitrogen), and 2% B27 (Invitrogen) was used according to the manufacturer’s instructions. Cell seeding was performed at 10 000 cells/well in 6-well ultra-low attachment plates (Corning).

Spheroids were obtained by centrifugation (200×g) and trypsin–EDTA digestion, followed by mechanical disruption. Single cells were washed and transferred into serum-free medium for sphere induction. Second-generation spheroids were used as lung cancer stem-like cells (LCSLCs).

Single cells with potential for transformation into new spheroids were cultured at 1000 cells/well in a 24-well plate to generate new spheroids. Tumor spheroids were counted in 6-day cultures; the efficiency of spheroid formation was derived as a ratio of total number of spheroids generated by that of H460 cells seeded, multiplied by 100.

In Vivo Tumorigenicity Experiments

Balb/c-nu mice aged 4 weeks were purchased from the Animal Institute of the Chinese Academy of Medical Science. All animal experiments were performed in accordance with the institutional guidelines of the Hunan Normal University. The University Committee on Animal Care and Hunan Normal University approved the experimental protocols (No. 2015-146). Mice were randomly divided into 3 groups (4 mice/group) and maintained under standard conditions, according to standard protocols. Cells were suspended in serum-free DMEM/Matrigel (BD Biosciences) mixture (1:1 volume). Each recipient Balb/c-nu mouse was inoculated subcutaneously with H460-derived LCSLCs (1×103, 1×104, and 1×105 cells) in 1 flank and monolayer H460 cells (1×104, 1×105, and 1×106) in the other, respectively. Tumorigenicity experiments were terminated 1 month after cell inoculation. The harvested tumors were imaged and weighed immediately. After that, specimens from tumor tissue samples were fixed with 10% neutral-buffered formalin, processed in paraffin blocks, and sectioned. The sections were stained with hematoxylin and eosin (H&E) and examined for histopathology.

Cell Transduction

Human NSCLC H460 cells or LCSLCs were seeded in 24-well culture plates at 40% to 50% confluence and incubated overnight. Then, cells were transduced with several plasmids using the enhanced infection solution (ENi.s, Catalog No. REVG0002; GeneChem, Shanghai, China). After 4 hours of transduction, DMEM with 10% fetal calf serum (FCS) was added to replace the transduction medium; this was followed by 48 hours of incubation before gene and protein-level assessments.

Western Blot

Cells lysis was performed according to published protocols.15 Monoclonal anti-β-actin, anti-Bmi1, and anti-FoxM1 antibodies and polyclonal anti-CD44, anti-ALDH1A1, anti-CD133, anti-Oct4, anti-Nanog, and anti-MnSOD antibodies were used as primary antibodies for overnight incubation at 4°C. Appropriate horseradish peroxidase-conjugated secondary antibodies were used for detection: After incubation for 1 hour at room temperature, visualization of specific protein bands was carried out by enhanced chemiluminescence, with β-actin employed for normalization.

Statistical Analysis

SPSS version 20.0 for Windows (SPSS Inc, Chicago, Illinois, USA) was used for statistical analyses. Data are mean (standard deviation) and were assessed by 1-way analysis of variance. First, homogeneity of variance was determined. Least-Significant Difference (LSD) was used to perform pairwise comparisons among groups. In case of incomplete variance, control and experimental groups were analyzed with Tukey test. A value of P < .05 was considered statistically significant.

Results

Spheroids From the H460 Cell Line Exhibit LCSLC Characteristics

Spheroids derived from the H460 cell line were cultured as suspension in stem cell conditioned medium. Then, the capability of self-renewal in both the spheroids and the H460 cells was assessed by the sphere-forming assay. Sphere-forming rates from spheroids were higher than those obtained with H460 monolayer cells, and second-generation spheroids had the highest potential of self-renewal (Figure 1A). These data suggested that LCSLC capacity of self-renewal was highly enhanced in H460 spheroids. In subsequent experiments, second-generation spheroids were used as LCSLCs.

Figure 1.

Figure 1.

Open in a new tab

Comparison of spheroid-forming rates. A, In spheroids of different generations (mean [SD], n = 3; *P < .05 vs primary spheroid culture; # P < .05 vs second or fourth spheroid culture); protein levels of stem cell markers (B) and transcription factors (C) in LCSLCs (second-generation spheroids) and cells in monolayer growth (n = 3; *P < .05 vs cells in monolayer growth). (D) The upper part is the table named that “Comparison of tumor formation ability of LCSLC and parental SMMC-7721 cells in balb/c-nu mice (n = 4)”. Histology (magnification: ×200) of xenografts inoculated with LCSLCs derived from H460 cells and the corresponding monolayer growth cells in nude mouse models were determined after hematoxylin and eosin staining. H460 indicates H460 cells in monolayer growth; LCSLC, lung cancer stem-like cells; SD, standard deviation.

To further confirm the LCSLC properties of H460 spheroids, protein expression levels of cancer stem cell (CSC)-related markers and transcription factors were compared between LCSLCs and H460 cells. Interestingly, Western blot demonstrated that protein expression levels of CSC-related biomarkers (CD133, CD44, and ALDH1; Figure 1B) and transcription factors (Bmi1, Nanog, and OCT4; Figure 1C) were elevated in LCSLCs compared to the values obtained for H460 cells. These results demonstrated that H460 spheroids possessed LCSLC properties, such as high capability of self-renewal in vitro and overexpression of “stemness” biomarkers.

To further evaluate the stem cell properties of H460-derived LCSLCs, we assessed the ability of H460-derived spheroids and monolayer cells to form tumors in Balb/c-nu mice. As many as 1 × 106 monolayer cells were needed to initiate stable tumor formation 24 (3) days after injection; in contrast, as few as 1× 103 H460-derived spheroids were sufficient to generate visible tumors only 17 (4) days postinjection. These data indicated that H460-derived spheroids, namely, LCSLCs, are more tumorigenic than the corresponding monolayer cells in vivo. Additionally, H&E staining was performed and revealed similar histological characteristics in tumor xenografts derived from H460 spheroids and the corresponding monolayer cells (Figure 1D). Collectively, these data demonstrated that H460 spheroids initiated tumors in vivo, suggesting that H460 spheroids may represent true LCSLCs in H460 cells.

Manganese Superoxide Dismutase and FoxM1 Protein Expression Levels Are Elevated in LCSLCs

The potential association of MnSOD with FoxM1 expression was assessed in both LCSLCs and H460 cells. As shown in Figure 2A, protein expression levels of MnSOD were markedly higher in LCSLCs compared to H460 cells. Interestingly, FoxM1 protein expression was also elevated in cells expressing high levels of MnSOD than in those with reduced MnSOD amounts (Figure 2B). These findings suggested that elevated MnSOD expression might be associated with FoxM1 upregulation in LCSLCs.

Figure 2.

Figure 2.

Open in a new tab

Comparison of MnSOD (A) and FoxM1 (B) protein expression levels in H460 cells in monolayer growth and spheroids of different generations (mean [SD], n = 3; *P < .05 vs H460 cells in monolayer growth; # P < .05 vs first-, third-, or fourth-spheroid generation from the H460 cell line). The representative western blot image of MnSOD, FoxM1, CD133, and CD44 protein bands in H441 (C, F), H1299 (D, G), and H358 (E, H) cells in monolayer growth and second-generation spheroids. Data shown are the mean of 3 separate experiments. *P < .05 vs H441 or H1299 or H358 cells in monolayer growth. FoxM1, forkhead box M1; MnSOD, manganese superoxide dismutase; SD, standard deviation.

We next assessed whether the expression levels of MnSOD and FoxM1 were also elevated in spheroids derived from other NSCLC cell lines, including H441, H1299, and H358. We found that the protein expression levels of MnSOD, FoxM1, and CSC-related biomarkers (CD133 and CD44) were markedly higher in second-generation spheroids compared to their respective monolayer cells in all 3 cell lines (Figure 2C-H). Together, these findings suggested that elevated expression levels of MnSOD and FoxM1 in spheroids were not specific to the H460 cell line.

Manganese Superoxide Dismutase Transduction Promotes MnSOD and FoxM1 Expression as well as Spheroid Formation in H460 Cells

Based on findings by Chen et al,8 demonstrating the crucial role of MnSOD in cancer via FoxM1 upregulation, we hypothesized that MnSOD could increase FoxM1 expression, thereby conferring self-renewal capability to LCSLCs.

To assess whether enhanced MnSOD expression affects FoxM1 expression levels and spheroid formation, MnSOD-carrying adenoviruses were used to generate MnSOD overexpressing H460 cells. Interestingly, MnSOD-expressing adenovirus-infected H460 cells showed markedly increased MnSOD and FoxM1 protein expression levels (Figure 3A). As shown in Figure 3B, elevated self-renewal potential was found in MnSOD overexpressing H460 cells. Furthermore, MnSOD expression modulated the protein expression levels of CD133, CD44, and ALDH1 (Figure 3C), and Bmi1, Nanog, and Oct4 (Figure 3D) in H460 cells. These findings suggested that MnSOD significantly regulated FoxM1 expression and LCSLC functions.

Figure 3.

Figure 3.

Open in a new tab

Effects of MnSOD transduction on protein expression of MnSOD and FoxM1 (A), spheroid formation (B), and expression levels of stem cell markers (C) and transcription factors (D) in H460 cells (mean [SD], n = 3; *P < .05 vs H460 cells; # P < .05 vs H460 cells expressing GFP). FoxM1 indicates forkhead box M1; MnSOD, manganese superoxide dismutase; SD, standard deviation.

Effects of FOXM1 Transduction on MnSOD and FoxM1 Expression, and Spheroid Formation in H460 Cells

To test the hypothesis that MnSOD may increase FoxM1 expression and confer self-renewal capability to LCSLCs, a FOXM1 expressing H460 cell clone was generated by infection with FOXM1-carrying adenoviruses.

Overexpression of FoxM1 was not accompanied by increased MnSOD protein expression (Figure 4A). However, it increased the sphere formation rate (Figure 4B). In addition, FoxM1 overexpression upregulated CD133, CD44, and ALDH1 (Figure 4C) as well as Bmi1, Sox2, and Oct4 (Figure 4D) in H460 cells following infection with FOXM1-carrying adenoviruses.

Figure 4.

Figure 4.

Open in a new tab

Effects of FOXM1 transduction on protein expression of MnSOD and FoxM1 (A), spheroid formation (B), and expression of stem cell markers (C), and transcription factors (D) in H460 cells (mean [SD], n = 3; *P < .05 vs H460 cells; # P < .05 vs H460 cells expressing GFP). FoxM1, forkhead box M1; MnSOD, manganese superoxide dismutase; SD, standard deviation.

Forkhead box M1 Expression and Spheroid Formation Are Dependent on MnSOD Expression in LCSLCs

To determine whether FoxM1 expression and spheroid formation are dependent on MnSOD expression, the MnSOD gene was silenced by infection with MnSOD short hairpin RNA (shRNA)-carrying adenoviruses.

MnSOD and FoxM1 protein levels in MnSOD knockdown LCSCs were significantly reduced compared with the values of control LCSLCs (Figure 5A). In addition, sphere formation assay revealed that MnSOD silencing resulted in decreased self-renewal capability in LCSLCs (Figures 5B). Furthermore, compared to LCSLCs, MnSOD knockdown led to reduced protein expression levels of CD133, CD44, and ALDH1 (Figure 5C) as well as Bmi1, Nanog, and Oct4 (Figure 5D). These findings suggested that FoxM1 expression and stemness in LCSLCs from H460 cells were dependent upon MnSOD.

Figure 5.

Figure 5.

Open in a new tab

Effects of MnSOD short hairpin RNA(shRNA) transduction on protein expression of MnSOD and FoxM1 (A), spheroid formation (B), and expression of stem cell markers (C) and transcription factors (D) in LCSLCs (second-generation spheroids) from the H460 cell line (mean [SD], n = 3; *P < .05 vs LCSLCs from the H460 cell line; # P < .05 vs LCSLCs from the H460 cell line expressing GFP). FoxM1 indicates forkhead box M1; MnSOD, manganese superoxide dismutase; SD, standard deviation.

Knockdown of FOXM1 Has No Effect on MnSOD Expression But Inhibits CSLC Properties in LCSLCs

To further confirm that MnSOD may increase FoxM1 expression and subsequently confer self-renewal capability to LCSLCs, we next silenced the FOXM1 gene by infection with FOXM1 shRNA-carrying adenoviruses.

Forkhead box M1 gene silencing resulted in decreased FoxM1 protein amounts, but had no effect on MnSOD levels (Figure 6A). Meanwhile, FOXM1 knockdown resulted in decreased self-renewal capability of LCSLCs (Figure 6B). Furthermore, FOXM1 knockdown resulted in reduced protein amounts of CD133, CD44, and ALDH1 (Figure 6C) as well as Bmi1, Sox2, and Oct4 (Figure 6D) in LCSLCs.

Figure 6.

Figure 6.

Open in a new tab

Effects of FOXM1 short hairpin RNA(shRNA) transduction on protein expression of MnSOD and FoxM1 (A), spheroid formation (B), and expression of stem cell markers (C) and transcription factors (D) in lung cancer stem-like cells (LCSLCs) from the H460 cell line (mean [SD], n = 3; *P < .05 vs LCSLCs from the H460 cell line; # P < .05 vs LCSLCs from the H460 cell line expressing GFP). FoxM1 indicates forkhead box M1; MnSOD, manganese superoxide dismutase; SD, standard deviation.

FOXM1 Transduction Alleviates the Inhibitory Effects of MnSOD Knockdown on FoxM1 Expression and CSLC Properties in LCSLCs

To establish the role of FoxM1 upregulation by MnSOD overexpression in maintaining LCSCL properties, the FOXM1 gene was transduced into MnSOD-silenced LCSLCs derived from the H460 cell line. As shown in Figure 7A, MnSOD shRNA downregulated MnSOD and FoxM1. Meanwhile, FOXM1 transduction increased FoxM1 protein expression without affecting MnSOD levels. Interestingly, FOXM1 gene transduction alleviated the inhibitory effects of MnSOD shRNA on self-renewal ability (Figure 7B) and CSC-related protein expression (Figure 7C and D) in LCSLCs from the H460 cell line.

Figure 7.

Figure 7.

Open in a new tab

Effects of FOXM1 Transduction in lung cancer stem-like cells (LCSLCs) expressing MnSOD short hairpin RNA(shRNA) on protein expression of MnSOD and FoxM1 (A), spheroid formation (B), and expression of stem cell markers (C) and transcription factors (D) (mean [SD], n = 3;*P < .05 vs LCSLCs from the H460 cell line; # P < .05 vs LCSLCs expressing MnSOD shRNA derived from the H460 cell line). FoxM1 indicates forkhead box M1; MnSOD, manganese superoxide dismutase; SD, standard deviation.

Discussion

This study first provided evidence, from assessing NSCLC H460 cells, that LCSLC stemness is promoted by MnSOD, via a mechanism involving up-regulation of the oncogenic transcription factor FoxM1. Our results showed that spheroids with LCSLC properties had upregulated MnSOD and FoxM1 protein expressions in parallel, compared to cells in monolayer growth from the H460, H441, H1299, and H358 cell lines. We also demonstrated that altering MnSOD and FoxM1 expression levels could change spheroid formation capabilities as well as the protein levels of CSC markers (CD133, CD44, and ALDH1) and multipotent transcription factors (Bmi1, Nanog, and OCT4). Importantly, FoxM1 protein expression, spheroid formation capability, and protein levels of CSC markers and multipotent transcription factors were dependent on MnSOD expression levels, as shown above, and FoxM1 overexpression alleviated the inhibitory effects of MnSOD silencing on LCSLC stemness in spheroids from H460 cells.

Although previous reports described MnSOD with tumor suppressive properties, multiple studies have demonstrated that it is highly expressed in multiple carcinomas such as gastric and colorectal carcinomas,16–18 glioblastoma,19 breast cancer,20,21 cervical cancer,22,23 prostate cancer,24 and lung cancer.8,25 Recently, it was shown that MnSOD expression and activity are associated with the functions and characteristics of CSCs or CSLCs.6,7,26–28 Here, we provided evidence that MnSOD participated in self-renewal capability as well as the expression of CSC markers and multipotent transcription factors in LCSLCs derived from NSCLC H460 cells. These results support the viewpoint that MnSOD induces CSLC properties in NSCLCs. A study by Meng et al 29 showed that genetic and epigenetic downregulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Therefore, miR-212 and MnSOD might be therapeutic targets for cancer.

Chen et al demonstrated that MnSOD expression is not changed by FoxM1-knockdown in A549 and H1355 cells, whereas MnSOD upregulates FoxM1 by releasing E2F1 and Sp1 transcription factors.8 As shown earlier, MnSOD protein levels did not change by FoxM1-silencing in spheroids derived from the H460 cell line. In human fibroblast cells, FoxM1 seems to regulate MnSOD expression at the messenger RNA and protein levels.30 Park et al described a negative feedback loop from FoxM1 to MnSOD that might control reactive oxygen species (ROS) in human fibroblast cell proliferation. Reactive oxygen species induce FoxM1, whereas elevated FoxM1, in turn, reduces ROS levels by promoting MnSOD expression.30 Based on the current findings and previous studies,30 we assume that FoxM1 upregulation by MnSOD is required to overcome ROS-induced oxidative stress occurring during lung cancer initiation and progression. How FoxM1 upregulation by MnSOD promotes LCSLC characteristics of NSCLC remains to be further elucidated.

Studies have shown that FoxM1 has an important function in maintaining stem cell pluripotency via regulation of Oct4, Nanog, and Sox2, in association with Wnt/β-catenin, to upregulate CSC markers (CD133, CD44, and ALDH1), contributing to CSC or CSLC characteristics.10,31,32 The present report provided experimental evidence that FoxM1 protein expression, spheroid formation capability, and the expression of CSC markers and multipotent transcription factors are dependent on MnSOD expression; in addition, FoxM1 gene transduction was shown to alleviate the inhibitory effects of MnSOD silencing on LCSLC functions and characteristics in spheroids derived from H460 cells. Accordingly, FoxM1 seems to be a performance effector for MnSOD functions.

In summary, the current study provides a mechanistic evidence to support the possibility that lung cancer CSC or CSLC properties are enhanced by FoxM1 activation through MnSOD overexpression. Our findings in NSCLC H460 cells were further supported by the evidence that elevated MnSOD expression in spheroids is associated with lung cancer carcinogenicity and progression. Inhibiting FoxM1 activation by MnSOD overexpression may represent an important novel strategy for LCSLCs in human NSCLC treatment.

Abbreviations

CSCs

cancer stem cells

CSLCs

cancer stem-like cells

DMEM

Dulbecco modified Eagle medium

FBS

fetal bovine serum

FoxM1

forkhead box M1

H&E

hematoxylin and eosin

LCSLCs

lung cancer stem-like cells

MnSOD

manganese superoxide dismutase

NSCLC

non-small cell lung cancer

ROS

reactive oxygen species

Footnotes

Authors’ Note: Zhimin Fu and Xiaocheng Cao contributed equally to this work.

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the National Natural Science Foundation of China (grant numbers 30760248 and 81172375). This project received financial support from Science and Technology Innovation Fund of Shenzhen (grant number JCYJ20140416122811926). This project also received financial support from Health and Family Planning Commission of Hunan Province (grant number B2016091).

ORCID iD: Zheng Wang, MD Inline graphic http://orcid.org/0000-0001-9252-2129

References

  • 1. Liu CC, Lin SP, Hsu HS, et al. Suspension survival mediated by PP2A-STAT3-Col XVII determines tumour initiation and metastasis in cancer stem cells. Nat Commun. 2016;7:11798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Seguin L, Kato S, Franovic A, et al. An integrin beta(3)-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition. Nat Cell Biol. 2014;16(5):457–468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Gong AH, Wei P, Zhang S, et al. FoxM1 drives a feed-forward STAT3-activation signaling loop that promotes the self-renewal and tumorigenicity of glioblastoma stem-like cells. Cancer Res. 2015;75(11):2337–2348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Chang KJ, Yang MH, Zheng JC, Li B, Nie W. Arsenic trioxide inhibits cancer stem-like cells via down-regulation of Gli1 in lung cancer. Am J Transl Res. 2016;8(2):1133–1143. [PMC free article] [PubMed] [Google Scholar]
  • 5. Liu F, Cao X, Liu Z, et al. Casticin suppresses self-renewal and invasion of lung cancer stem-like cells from A549 cells through down-regulation of pAkt. Acta Biochim Biophys Sin (Shanghai). 2014;46(1):15–21. [DOI] [PubMed] [Google Scholar]
  • 6. Shen YA, Wang CY, Hsieh YT, Chen YJ, Wei YH. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma. Cell Cycle. 2015;14(1):86–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Hart PC, Mao M, de Abreu AL, et al. MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer. Nat Commun. 2015;6:6053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Chen PM, Wu TC, Shieh SH, et al. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas. Mol Cancer Res. 2013;11(3):261–271. [DOI] [PubMed] [Google Scholar]
  • 9. Kwok CT, Leung MH, Qin J, et al. The forkhead box transcription factor FOXM1 is required for the maintenance of cell proliferation and protection against oxidative stress in human embryonic stem cells. Stem Cell Res. 2016;16(3):651–661. [DOI] [PubMed] [Google Scholar]
  • 10. Zhang N, Wei P, Gong A, et al. FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell. 2011;20(4):427–442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Xu N, Jia D, Chen W, et al. FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis. PloS One. 2013;8(3):e59412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Wang IC, Meliton L, Tretiakova M, Costa RH, Kalinichenko VV, Kalin TV. Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors. Oncogene. 2008;27(30):4137–4149. [DOI] [PubMed] [Google Scholar]
  • 13. Bao B, Wang Z, Ali S, et al. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem. 2011;112(9):2296–2306. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 14. Joshi K, Banasavadi-Siddegowda Y, Mo X, et al. MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells. Stem Cells. 2013;31(6):1051–1063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Ren KQ, Cao XZ, Liu ZH, et al. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of twist signaling. Int J Oncol. 2013;43(5):1719–1729. [DOI] [PubMed] [Google Scholar]
  • 16. Kim JJ, Chae SW, Hur GC, et al. Manganese superoxide dismutase expression correlates with a poor prognosis in gastric cancer. Pathobiology. 2002;70(6):353–360. [DOI] [PubMed] [Google Scholar]
  • 17. Malafa M, Margenthaler J, Webb B, Neitzel L, Christophersen M. MnSOD expression is increased in metastatic gastric cancer. J Surg Res. 2000;88(2):130–134. [DOI] [PubMed] [Google Scholar]
  • 18. Mohr A, Buneker C, Gough RP, Zwacka RM. MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release. Oncogene. 2008;27(6):763–774. [DOI] [PubMed] [Google Scholar]
  • 19. Ria F, Landriscina M, Remiddi F, et al. The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications. Br J Cancer. 2001;84(4):529–534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Kattan Z, Minig V, Leroy P, Dauca M, Becuwe P. Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells. Breast Cancer Res Treat. 2008;108(2):203–215. [DOI] [PubMed] [Google Scholar]
  • 21. Ennen M, Minig V, Grandemange S, et al. Regulation of the high basal expression of the manganese superoxide dismutase gene in aggressive breast cancer cells. Free Radic Biol Med. 2011;50(12):1771–1779. [DOI] [PubMed] [Google Scholar]
  • 22. Palazzotti B, Pani G, Colavitti R, et al. Increased growth capacity of cervical-carcinoma cells over-expressing manganous superoxide dismutase. Int J Cancer. 1999;82(1):145–150. [DOI] [PubMed] [Google Scholar]
  • 23. Wang W, Jia HL, Huang JM, et al. Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics. Br J Cancer. 2014;110(7):1748–1758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Quiros-Gonzalez I, Sainz RM, Hevia D, Mayo JC. MnSOD drives neuroendocrine differentiation, androgen independence, and cell survival in prostate cancer cells. Free Radic Biol Med. 2011;50(4):525–536. [DOI] [PubMed] [Google Scholar]
  • 25. Chen PM, Cheng YW, Wu TC, Chen CY, Lee H. MnSOD overexpression confers cisplatin resistance in lung adenocarcinoma via the NF-kappaB/Snail/Bcl-2 pathway. Free Radic Biol Med. 2015;79:127–137. [DOI] [PubMed] [Google Scholar]
  • 26. Iglesias-Bartolome R, Patel V, Cotrim A, et al. mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell. 2012;11(3):401–414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Niu Y, Epperly MW, Shen H, Smith T, Wang H, Greenberger JS. Intraesophageal MnSOD-plasmid liposome enhances engraftment and self-renewal of bone marrow derived progenitors of esophageal squamous epithelium. Gene Ther. 2008;15(5):347–356. [DOI] [PubMed] [Google Scholar]
  • 28. Kumar AP, Loo SY, Shin SW, et al. Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma. Antioxid Redox Signal. 2014;20(15):2326–2346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Meng X, Wu J, Pan C, et al. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Gastroenterology. 2013;145(2):426–436. e1–e6. [DOI] [PubMed] [Google Scholar]
  • 30. Park HJ, Carr JR, Wang Z, et al. FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J. 2009;28(19):2908–2918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Xie Z, Tan G, Ding M, et al. Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells. Nucleic Acids Res. 2010;38(22):8027–8038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Gemenetzidis E, Elena-Costea D, Parkinson EK, Waseem A, Wan H, Teh MT. Induction of human epithelial stem/progenitor expansion by FOXM1. Cancer Res. 2010;70(22):9515–9526. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Technology in Cancer Research & Treatment are provided here courtesy of SAGE Publications

RESOURCES